Adam David Cohen (Adam Cohen, Adam D Cohen)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 19

Top Topics

Multiple Myeloma

Acute Lymphoblastic Leukemia

Monoclonal Antibody

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Yan Tang, Wei Liu, Siddhant Kadu, Omar Johnson, Zainul Shoyeb Hasanali, Andre R Kelly, Alexander A Shestov, Eli Greenblat, Matthew Holmes, Li-Ping Wang, Natalie Shih, Roddy S O'Connor, Alfred L Garfall, David Allman, Dan T Vogl, Adam David Cohen, Carl H June, Neil C Sheppard
Exploiting the CD200-CD200R Immune Checkpoint Axis in Multiple Myeloma to Enhance CAR-T Therapy. Blood (2023)
Morie A Gertz, Adam David Cohen, Raymond L Comenzo, Efstathios Kastritis, Heather J Landau, Edward N Libby, Michaela Liedtke, Vaishali Sanchorawala, Stefan Schönland, Ashutosh D Wechalekar, Jeffrey A Zonder, Giovanni Palladini, Jackie Walling, Spencer Guthrie, Christie Nie, Carol Karp, Yuying Jin, Gene G Kinney, Giampaolo Merlini
Birtamimab plus standard of care in light chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial. Blood (2023)
Adam David Cohen, Samir Parekh, Bianca D Santomasso, Jaime Gállego Pérez-Larraya, Niels W C J van de Donk, Bertrand Arnulf, Maria-Victoria Mateos-Manteca, Nikoletta Lendvai, Carolyn C Jackson, Kevin C De Braganca, Jordan M Schecter, Loreta Marquez, Erin Lee, Ingrid Cornax, Enrique Zudaire, Claire Li, Yunsi Olyslager, Deepu Madduri, Helen Varsos, Lida Pacaud, Muhammad Akram, Dong Geng, Andrzej J Jakubowiak, Hermann Einsele, Sundar Jagannath
Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies. Blood cancer journal 12 (2) (2022)
Thomas Martin, Saad Z Usmani, Jesus G Berdeja, Mounzer Agha, Adam David Cohen, Parameswaran N Hari, David Avigan, Abhinav Deol, Myo Htut, Alexander Lesokhin, Nikhil C Munshi, Elizabeth O'Donnell, A Keith Stewart, Jordan M Schecter, Jenna D Goldberg, Carolyn C Jackson, Tzu-Min Yeh, Arnob Banerjee, Alicia Allred, Enrique Zudaire, William Deraedt, Yunsi Olyslager, Changwei Zhou, Lida Pacaud, Deepu Madduri, Andrzej J Jakubowiak, Yi Lin, Sundar Jagannath
Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Sandra P Susanibar-Adaniya, Edward A Stadtmauer, Adam David Cohen
CAR T cell therapy for multiple myeloma: What have we learned? Leukemia 36 (6) (2022)
Adam David Cohen, Maria-Victoria Mateos-Manteca, Yael C Cohen, Paula Rodriguez-Otero, Juan José Lahuerta, Niels W C J van de Donk, Thomas G Martin, Attaya Suvannasankha, Kevin C De Braganca, Christina Corsale, Jordan M Schecter, Helen Varsos, William Deraedt, Liwei Wang, Martin Vogel, Tito Roccia, Xiaoying Xu, Pankaj Mistry, Enrique Zudaire, Muhammad Akram, Tonia Nesheiwat, Lida Pacaud, Irit Avivi, Jesús San F Miguel
Efficacy and safety of cilta-cel in patients with progressive MM after exposure to other BCMA-targeting agents. Blood (2022)
Alfred L Garfall, Adam David Cohen, Sandra P Susanibar-Adaniya, Wei-Ting Hwang, Dan T Vogl, Adam J Waxman, Simon F Lacey, Vanessa E Gonzalez, Joseph A Fraietta, Minnal Gupta, Irina Kulikovskaya, Lifeng Tian, Fang Chen, Natalka Koterba, Robert L Bartoszek, Margaret Patchin, Rong Xu, Gabriela Plesa, Donald L Siegel, Andrea Brennan, Anne Marie Nelson, Regina Ferthio, Angela Cosey, Kim-Marie Shea, Rachel Leskowitz, Megan Four, Wesley V Wilson, Fei Miao, Eric Lancaster, Beatriz M Carreno, Gerald P Linette, Elizabeth O Hexner, Regina M Young, Dexiu Bu, Keith G Mansfield, Jennifer L Brogdon, Carl H June, Michael C Milone, Edward A Stadtmauer
Anti-BCMA/CD19 CAR T cells with early immunomodulatory maintenance for multiple myeloma responding to initial or later-line therapy. Blood cancer discovery (2022)
Kavita M Dhodapkar, Adam David Cohen, Akhilesh Kaushal, Alfred L Garfall, Renee Julia Manalo, Allison R Carr, Samuel S McCachren, Edward A Stadtmauer, Simon F Lacey, Jan Joseph Melenhorst, Carl H June, Michael C Milone, Madhav V Dhodapkar
Changes in Bone Marrow Tumor and Immune Cells Correlate with Durability of Remissions Following BCMA CAR T Therapy in Myeloma. Blood cancer discovery 3 (6) (2022)
Luca Bernabei, Lifeng Tian, Alfred L Garfall, J Joseph Melenhorst, Simon F Lacey, Edward A Stadtmauer, Dan T Vogl, Vanessa E Gonzalez, Gabriela Plesa, Regina M Young, Adam Waxman, Bruce L Levine, Carl H June, Michael C Milone, Adam David Cohen
B-cell maturation antigen chimeric antigen receptor T-cell re-expansion in a patient with myeloma following salvage programmed cell death protein 1 inhibitor-based combination therapy. British journal of haematology 193 (4) (2021)
Alfred L Garfall, Adam David Cohen, Edward Stadtmauer, Sandra P Susanibar-Adaniya, Dan T Vogl, Adam J Waxman
Overall Survival Remains Important in Trials of Early-Line Multiple Myeloma Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Muzaffar H Qazilbash, Neeraj Y Saini, Cha Soung-Chul, Zhe Wang, Edward Stadtmauer, Veerabhadran Baladandayuthapani, Heather Lin, Beryl Tross, Medhavi Honhar, Sheetal S Rao, Kunhwa Kim, Michael Popescu, Szymon Jakub Szymura, Tiantian Zhang, Aaron J Anderson, Qaiser Bashir, Elizabeth J Shpall, Robert Z Orlowski, Bruce L Levine, Naseem Kerr, Alfred L Garfall, Adam David Cohen, Dan T Vogl, Karen Dengel, Carl H June, Richard E Champlin, Larry W Kwak
A Randomized Phase II Trial of Idiotype Vaccination and Adoptive Autologous T-Cell Transfer in Multiple Myeloma patients. Blood (2021)
Shwetha H Manjunath, Adam David Cohen, Simon F Lacey, Megan M Davis, Alfred L Garfall, J Joseph Melenhorst, Russell Maxwell, W Tristram Arscott, Amit Maity, Joshua A Jones, John P Plastaras, Edward A Stadtmauer, Bruce L Levine, Carl H June, Michael C Milone, Ima Paydar
The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Edward A Stadtmauer, Joseph A Fraietta, Megan M Davis, Adam David Cohen, Kristy L Weber, Eric Lancaster, Patricia A Mangan, Irina Kulikovskaya, Minnal Gupta, Fang Chen, Lifeng Tian, Vanessa E Gonzalez, Jun Xu, In-Young Jung, J Joseph Melenhorst, Gabriela Plesa, Joanne Shea, Tina Matlawski, Amanda Cervini, Avery L Gaymon, Stephanie Desjardins, Anne Lamontagne, January Salas-Mckee, Andrew D Fesnak, Donald L Siegel, Bruce L Levine, Julie K Jadlowsky, Regina M Young, Anne Chew, Wei-Ting Hwang, Elizabeth O Hexner, Beatriz M Carreno, Christopher L Nobles, Frederic D Bushman, Kevin R Parker, Yanyan Qi, Ansuman T Satpathy, Howard Y Chang, Yangbing Zhao, Simon F Lacey, Carl H June
CRISPR-engineered T cells in patients with refractory cancer. Science (New York, N.Y.) 367 (6481) (2020)
Paul G Richardson, Hans C Lee, Al-Ola Abdallah, Adam David Cohen, Prashant Kapoor, Peter M Voorhees, Axel Hoos, Karrie Wang, January Baron, Trisha Piontek, Julie Byrne, Scott Richmond, Roxanne C Jewell, Joanna Opalinska, Ira Gupta, Sagar Lonial
Single-agent belantamab mafodotin for relapsed/refractory multiple myeloma: analysis of the lyophilised presentation cohort from the pivotal DREAMM-2 study. Blood cancer journal 10 (10) (2020)
Alfred L Garfall, Ehren K Dancy, Adam David Cohen, Wei-Ting Hwang, Joseph A Fraietta, Megan M Davis, Bruce L Levine, Don L Siegel, Edward A Stadtmauer, Dan T Vogl, Adam Waxman, Aaron P Rapoport, Michael C Milone, Carl H June, J Joseph Melenhorst
T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma. Blood advances 3 (19) (2020)
Adam David Cohen, Alfred L Garfall, Ahmet Dogan, Simon F Lacey, Chris Martin, Nikoletta Lendvai, Dan T Vogl, Matthew Spear, Alexander M Lesokhin
Serial treatment of relapsed/refractory multiple myeloma with different BCMA-targeting therapies. Blood advances 3 (16) (2020)
Sikander Ailawadhi, Rachael Sexton, Suzanne Lentzsch, Muneer H Abidi, Peter M Voorhees, Adam David Cohen, Eric M Rohren, Stephen B Heitner, Kevin Kelly, Niklas J Mackler, David M Baer, Antje Hoering, Brian Durie, Robert Z Orlowski
Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (15) (2020)
Adam David Cohen, Noopur Raje, Jessica A Fowler, Khalid Mezzi, Emma C Scott, Madhav V Dhodapkar
How to Train Your T Cells: Overcoming Immune Dysfunction in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (7) (2019)
Tatiana Pazina, Ashley M James, Kimberly B Colby, Yibin Yang, Andrew N Gale, Amy Jhatakia, Alper Y Kearney, Robert F Graziano, Natalie A Bezman, Michael D Robbins, Adam David Cohen, Kerry S Campbell
Enhanced SLAMF7 Homotypic Interactions by Elotuzumab Improves NK Cell Killing of Multiple Myeloma. Cancer immunology research 7 (10) (2019)